STX2 (syntaxin-2) is a SNARE protein with critical roles in membrane trafficking and exocytosis. Primary function: STX2 localizes to the plasma membrane, early endosomes, and phagosomes, where it regulates vesicle docking and fusion events 1. The protein coordinates surface receptor density, phagosome biogenesis, and maturation in macrophages; STX2 knockdown increases phagocytic uptake of IgG-opsonized particles but impairs phagolysosomal maturation and bacterial degradation 1. Mechanism: STX2 functions as part of the SNARE complex mediating calcium-dependent exocytosis and intracellular protein transport. In vascular endothelial cells, STX2 modulates tissue plasminogen activator (tPA) release; silencing STX2 increases tPA secretion, suggesting a regulatory role in exocytotic control 2. Disease relevance: While STX2 is distinct from Shiga toxin 2 (also abbreviated Stx2), the abstracts repeatedly reference Shiga toxin's pathogenic mechanisms in hemolytic uremic syndrome, involving Gb3 receptor binding and translocation across epithelial barriers 3. Clinical significance: Understanding STX2's role in regulating phagolysosomal clearance and receptor trafficking suggests potential therapeutic targets for modulating aberrant phagocytosis and controlling intracellular bacterial persistence 1. Genome-wide association studies identify STX2 variants associated with circulating tPA levels, linking the protein to cardiovascular physiology 2.